UCL Institute of Cardiovascular Science


A comparison of US and (proposed) UK cholesterol guidelines
Mon 14th April
2nd floor seminar room
Rayne Building
5 University Street, London WC1E 6JF

Challenges and Innovations in Cardiometabolic Disease
Fri 9th May
Wellcome Collection
183 Euston Road, London NW1 2BE
Programme and registration

American Heart Association: Arteriosclerosis, Thrombosis
and Vascular Biology 2014
1st - 3rd May
Sheraton Centre Toronto Hotel
Toronto, Ontario, Canada
Call for abstracts and preliminary programme

Yale UCL Device Summit

Date: 17-18th January 2013

Time: All day

Location: Kings Place, 90 York Way, London N1 9AG

Cost: Registration is free but numbers are limited

The Cardiovascular Device Innovation Summit is a day and a half of interactive discussions with full audience participation focused on EU/US innovation pathways for new interventional devices.  Leading UK policy makers, NIH and NIHR funders, MHRA and FDA device regulators, VC funders, bioengineers, clinicians, legal and both start-up and mature device industry will provide a realistic and global perspective of current pathways and “sticking points” to enable and facilitate cardiovascular device development from early concept to clinical evaluation and market commercialization.  Our goal is to engage in an open critical dialogue of experts to provide insight into the global landscape of device innovation in specific therapeutic areas which include:

•    Transcatheter Aortic Valve Implantation and NeuroProtection devices
•    Percutaneous Mitral Devices
•    Next generation Drug Eluting Stents and Bioresorbable Scaffolds

Audience participation will be actively encouraged to provide input on clinical need and perspectives.  

Download full programme here